Immunogenicity and safety of heterologous versus homologous prime-boost schedules with an adenoviral vectored and mRNA COVID-19 vaccine: a systematic review

BACKGROUND: Heterologous prime-boost with ChAdOx1 nCoV-19 vector vaccine (ChAd) and a messenger RNA vaccine (BNT or mRNA-1273) has been widely facilitating mass coronavirus disease 2019 (COVID-19) immunisation. This review aimed to synthesize immunogenicity and reactogenicity of heterologous immunis...

Descripción completa

Detalles Bibliográficos
Autores principales: Lv, Jingjing, Wu, Hui, Xu, Junjie, Liu, Jiaye
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Scoping Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9100319/
https://www.ncbi.nlm.nih.gov/pubmed/35562753
http://dx.doi.org/10.1186/s40249-022-00977-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9100319/
https://www.ncbi.nlm.nih.gov/pubmed/35562753
http://dx.doi.org/10.1186/s40249-022-00977-x

Ejemplares similares